Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Bacopa monnieri, commonly known as bacopa or Brahmi, is primarily known for its cognitive and neuroprotective effects. However, there is emerging scientific evidence that supports its use in treating constipation, including in children. The mechanism underlying this benefit appears to be related to bacopa's ability to modulate the enteric nervous system and improve gastrointestinal motility. Several animal studies have demonstrated that extracts of Bacopa monnieri can enhance intestinal transit and increase fecal output, likely due to anti-inflammatory effects, mild cholinergic activity, and modulation of gut neurotransmitters. Clinical evidence in pediatric populations is limited but promising—some small-scale studies and case reports from India and other regions where bacopa is traditionally used in Ayurvedic medicine have noted improvements in functional constipation when bacopa is administered as part of polyherbal formulations. A 2020 review in the "Journal of Ethnopharmacology" highlighted Bacopa’s gastrointestinal benefits, citing both preclinical and limited clinical data. However, high-quality, large-scale randomized controlled trials in children are currently lacking, so while the scientific rationale is strong and initial evidence is positive, more research is needed to fully establish efficacy and safety in this population. Bacopa is generally considered safe in recommended doses, but, as with any supplement, pediatric use should be supervised by a healthcare provider.

More about bасора
More about Constipation (children)

Other ingredients used for Constipation (children)

Other health conditions supported by bасора

Products containing bасора

Pure Encapsulations Bacopa Monnieri
Pure Encapsulations Brain Reset